Digital Support for Caregivers
Trial Summary
Do I need to stop my current medications to join the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Altitudes, Altitudes for Caregivers, Digital Behavioral Health and Psychoeducational Intervention for Caregivers?
Research shows that digital psychoeducation and peer support can improve mental health and caregiving skills for caregivers, as seen in studies like Tele-Savvy and COPe-support, which have been effective in reducing stress and improving wellbeing for caregivers of individuals with dementia and psychosis.12345
Is the Digital Support for Caregivers treatment safe for participants?
How does the digital support treatment for caregivers differ from other treatments?
This digital support treatment is unique because it focuses on providing mental health support to caregivers through online tools, which are accessible, low-cost, and time-effective. Unlike traditional treatments that may focus on specific coping skills or education, this approach aims to reduce caregiver burden by offering comprehensive support through virtual meetings and cognitive-behavioral therapy.1112131415
What is the purpose of this trial?
The purpose of the present study is to investigate the feasibility, accessibility, and potential clinical benefits of implementing a moderated online social media platform with therapeutic content, Altitudes, to parents, caregivers, and supporters of young people with psychosis across the state of North Carolina, including in Coordinated Specialty Care (CSC) programs, Specialized Treatment Early in Psychosis (STEP) programs, and other community services where caregivers or supporters of young persons experiencing psychosis receive care. The investigators will evaluate acceptability and feasibility with up to 50 caregivers and supporters over the course of 6 months. Acceptability and usability will be assessed with various acceptability measures with the Altitudes caregivers and supporters, and caregivers and supporters' engagement with the digital platform. The investigators will additionally evaluate the impact of the platform on caregiver and supporter's psychological status, well-being, and social support, as measured via self-report questionnaires.
Research Team
Kelsey R Ludwig, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Diana Perkins, MD, MPH
Principal Investigator
University of North Carolina, Chapel Hill
Eligibility Criteria
This trial is for caregivers and supporters of young people with psychosis in North Carolina. Participants should be involved in programs like CSC, STEP, or similar community services. The study aims to include up to 50 individuals who can commit to a 6-month period.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Onboarding
Participants receive instructions and guidance for using the Altitudes platform
Treatment
Participants engage with the Altitudes digital platform, including psychoeducational and therapeutic content, for approximately 6 months
Follow-up
Participants are monitored for engagement and psychological status, well-being, and social support through self-report questionnaires
Treatment Details
Interventions
- Altitudes
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
North Carolina Department of Health and Human Services
Collaborator